| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1454 | 2018 |
| Detection and interpretation of shared genetic influences on 42 human traits JK Pickrell, T Berisa, JZ Liu, L Ségurel, JY Tung, DA Hinds Nature genetics 48 (7), 709-717, 2016 | 1222 | 2016 |
| New appendix criteria open for a broader concept of chronic migraine J Olesen, MG Bousser, HC Diener, D Dodick, M First, PJ Goadsby, ... Cephalalgia 26 (6), 742-746, 2006 | 1092 | 2006 |
| Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine P Gormley, V Anttila, BS Winsvold, P Palta, T Esko, TH Pers, KH Farh, ... Nature genetics 48 (8), 856-866, 2016 | 774 | 2016 |
| The international classification of headache disorders, (beta version) DA Ettlin Cephalalgia 33 (9), 629-808, 2013 | 647 | 2013 |
| Genome-wide association study of migraine implicates a common susceptibility variant on 8q22. 1 Nature genetics 42 (10), 869-873, 2010 | 500 | 2010 |
| The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society H Göbel, M Petersen-Braun, D Soyka Cephalalgia 14 (2), 97-106, 1994 | 496 | 1994 |
| Genome-wide meta-analysis identifies new susceptibility loci for migraine V Anttila, BS Winsvold, P Gormley, T Kurth, F Bettella, G McMahon, ... Nature genetics 45 (8), 912-917, 2013 | 481 | 2013 |
| Genome-wide association analysis identifies susceptibility loci for migraine without aura T Freilinger, V Anttila, B De Vries, R Malik, M Kallela, GM Terwindt, ... Nature genetics 44 (7), 777-782, 2012 | 427 | 2012 |
| The International Classification of Headache Disorders, 2nd Edition (ICHD-II)—-Revision of Criteria for 8.2 Medication-Overuse Headache SD Silberstein, J Olesen, MG Bousser, HC Diener, D Dodick, M First, ... Cephalalgia 25 (6), 460-465, 2005 | 423 | 2005 |
| Petasites hybridus root (butterbur) is an effective preventive treatment for migraine RB Lipton, H Gobel, KM Einhaupl, K Wilks, A Mauskop Neurology 63 (12), 2240-2244, 2004 | 380 | 2004 |
| Magnesium in the prophylaxis of migraine—a double-blind, placebo-controlled study V Pfaffenrath, P Wessely, C Meyer, HR Isler, S Evers, KH Grotemeyer, ... Cephalalgia 16 (6), 436-440, 1996 | 342 | 1996 |
| Die Kopfschmerzen H Göbel Springer Berlin Heidelberg, 2012 | 297 | 2012 |
| Effect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters H Göbel, G Schmidt, D Soyka Cephalalgia 14 (3), 228-234, 1994 | 271 | 1994 |
| Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants K Jurkat-Rott, T Freilinger, JP Dreier, J Herzog, H Gobel, GC Petzold, ... Neurology 62 (10), 1857-1861, 2004 | 228 | 2004 |
| Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial HP Mattle, S Evers, D Hildick-Smith, WJ Becker, H Baumgartner, ... European heart journal 37 (26), 2029-2036, 2015 | 216 | 2015 |
| Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study SD Silberstein, H Göbel, R Jensen, AH Elkind, R Degryse, JMCM Walcott, ... Cephalalgia 26 (7), 790-800, 2006 | 208 | 2006 |
| Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport®) for the relief of upper back myofascial pain syndrome: Results from a randomized double … H Göbel, A Heinze, G Reichel, H Hefter, R Benecke, ... Pain 125 (1), 82-88, 2006 | 204 | 2006 |
| Epidemiologie und Kosten chronischer Schmerzen H Göbel Der Schmerz 15 (2), 92-98, 2001 | 189 | 2001 |
| Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks T EMSASI, HC Diener, G Bussone, H de Liano, A Eikermann, R Englert, ... Cephalalgia 24 (11), 947-954, 2004 | 161 | 2004 |